They do not contain any of the GLP-1 drugs
It is usually administered once weekly or once monthly, depending on the dose and formulation
The agency cited immunogenicity concerns, saying there was limited data on the quality, stability and consistency of the compounds
Nutritional priorities to support GLP-1 therapy for obesity: a joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and the Obesity Society
Understanding which entity does what is the foundation for evaluating whether this program fits your situation
Many individuals notice reduced hunger and increased fullness within the first one to two weeks, while noticeable weight loss often takes several weeks longer